BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36543994)

  • 1. Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea.
    Ju W; Zheng R; Zhang S; Zeng H; Sun K; Wang S; Chen R; Li L; Wei W; He J
    Sci China Life Sci; 2023 May; 66(5):1079-1091. PubMed ID: 36543994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of cancer and changing cancer spectrum among older adults in China: Trends and projections to 2030.
    Shi Z; Lin J; Wu Y; Fu S; Wan Y; Fang Y
    Cancer Epidemiol; 2022 Feb; 76():102068. PubMed ID: 34864577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
    Xia C; Dong X; Li H; Cao M; Sun D; He S; Yang F; Yan X; Zhang S; Li N; Chen W
    Chin Med J (Engl); 2022 Feb; 135(5):584-590. PubMed ID: 35143424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA.
    Wu SL; Zhang Y; Fu Y; Li J; Wang JS
    BMJ Open; 2022 Jul; 12(7):e061038. PubMed ID: 35863834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020.
    Qiu H; Cao S; Xu R
    Cancer Commun (Lond); 2021 Oct; 41(10):1037-1048. PubMed ID: 34288593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea.
    Yang S; Lin S; Li N; Deng Y; Wang M; Xiang D; Xiang G; Wang S; Ye X; Zheng Y; Yao J; Zhai Z; Wu Y; Hu J; Kang H; Dai Z
    J Hematol Oncol; 2020 Nov; 13(1):146. PubMed ID: 33138852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of cancer incidence and mortality in elderly population in China, 2013].
    Chen WQ; Zheng RS; Zhang SW; Zeng HM; Zou XN; He J
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):60-66. PubMed ID: 28104036
    [No Abstract]   [Full Text] [Related]  

  • 8. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020.
    Lei S; Zheng R; Zhang S; Wang S; Chen R; Sun K; Zeng H; Zhou J; Wei W
    Cancer Commun (Lond); 2021 Nov; 41(11):1183-1194. PubMed ID: 34399040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Cancer Incidence and Mortality in Korea, 2016.
    Jung KW; Won YJ; Oh CM; Kong HJ; Cho H; Lee JK; Lee DH; Lee KH
    Cancer Res Treat; 2016 Apr; 48(2):451-7. PubMed ID: 27034143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Cancer Incidence and Mortality in Korea, 2023.
    Jung KW; Kang MJ; Park EH; Yun EH; Kim HJ; Kong HJ; Im JS; Seo HG
    Cancer Res Treat; 2023 Apr; 55(2):400-407. PubMed ID: 36915244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Cancer Incidence and Mortality in Korea, 2020.
    Jung KW; Won YJ; Hong S; Kong HJ; Lee ES
    Cancer Res Treat; 2020 Apr; 52(2):351-358. PubMed ID: 32178488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Cancer Incidence and Mortality in Korea, 2022.
    Jung KW; Won YJ; Kang MJ; Kong HJ; Im JS; Seo HG
    Cancer Res Treat; 2022 Apr; 54(2):345-351. PubMed ID: 35313101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer burden and trends in China: A review and comparison with Japan and South Korea.
    Sun D; Cao M; Li H; He S; Chen W
    Chin J Cancer Res; 2020 Apr; 32(2):129-139. PubMed ID: 32410791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Cancer Incidence and Mortality in Korea, 2018.
    Jung KW; Won YJ; Kong HJ; Lee ES
    Cancer Res Treat; 2018 Apr; 50(2):317-323. PubMed ID: 29566480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Cancer Incidence and Mortality in Korea, 2021.
    Jung KW; Won YJ; Hong S; Kong HJ; Im JS; Seo HG
    Cancer Res Treat; 2021 Apr; 53(2):316-322. PubMed ID: 33735558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea.
    Lin Y; Wu Y
    Cancer Sci; 2023 Oct; 114(10):4052-4062. PubMed ID: 37488752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fractions and trends of cancer burden attributable to population ageing in China].
    Xia CF; Chen WQ
    Zhonghua Zhong Liu Za Zhi; 2022 Jan; 44(1):79-85. PubMed ID: 35073652
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women.
    Shin HR; Joubert C; Boniol M; Hery C; Ahn SH; Won YJ; Nishino Y; Sobue T; Chen CJ; You SL; Mirasol-Lumague MR; Law SC; Mang O; Xiang YB; Chia KS; Rattanamongkolgul S; Chen JG; Curado MP; Autier P
    Cancer Causes Control; 2010 Nov; 21(11):1777-85. PubMed ID: 20559704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disease burden of colorectal cancer in China: any changes in recent years?].
    Wang H; Cao MD; Liu CC; Yan XX; Huang HY; Zhang Y; Chen HD; Ren JS; Li N; Chen WQ; Dai M; Shi JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1633-1642. PubMed ID: 33297619
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence].
    Cao MD; Wang H; Shi JF; Bai FZ; Cao MM; Wang YT; Yan XX; Wang L; Huang Z; Ren JS; Zhao JJ; Dai M; Qu CF; Chen WQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1848-1858. PubMed ID: 33297650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.